Finance

US Measles Cases in 2026 Already Pass 2025's Full-Year Total, Driven Mostly by Clusters

Marcus SterlingPublished 4m ago3 min readBased on 1 source
Reading level
US Measles Cases in 2026 Already Pass 2025's Full-Year Total, Driven Mostly by Clusters
Photo by KOBU Agency on Unsplash

The U.S. Centers for Disease Control and Prevention (CDC) reported 5,412 confirmed measles cases in the United States in 2026 as of November 12, in data published on its measles data and research page on November 13. Of those cases, 5,394 were reported by 47 U.S. jurisdictions (states, cities, and territories that report to the federal government). The remaining 18 were among international visitors to the country.

The 2026 figure already exceeds the 2,289 confirmed cases the CDC reported for all of 2025. That year's total was split between 2,263 cases reported by 45 jurisdictions and 26 among international visitors. The year-to-date count is roughly 2.4 times the prior year's full total, and several weeks of reporting remain before the calendar year closes.

The outbreak structure matters as much as the headline count. The CDC defines a measles outbreak as three or more related cases, so an outbreak is a small chain of linked infections rather than a single stray case. In 2026, 43 new outbreaks were reported, and 96% of confirmed cases (5,216 of 5,412) were outbreak-associated. Of those, 3,831 came from outbreaks that began in 2026, and 1,385 came from outbreaks that started in 2025. Put another way, roughly one case in four this year traces to a cluster that was already active when 2025 ended.

The comparison years show the trend. In 2025, the CDC reported 48 outbreaks, and 90% of confirmed cases (2,066 of 2,289) were outbreak-associated. In 2024, it reported 16 outbreaks, with 69% of cases (198 of 285) outbreak-associated. The share of cases tied to identifiable clusters has risen in each of the last two years, from 69% to 90% to 96%.

The count also has a specific scope. The CDC's case data includes only confirmed cases as notified by jurisdictions. Probable cases are not included. Totals therefore reflect laboratory- or criteria-confirmed notifications that have reached the federal tally, and they can move as state and local health departments report or reclassify cases. Comparisons against earlier years should use the same basis.

The broader context here is a shift in how transmission is happening. A high outbreak-associated share means most cases are linked to chains of related infections that health authorities can, in principle, identify and trace. A low share would point toward scattered, unlinked cases. The 2026 pattern points toward clusters. The carryover of 1,385 cases from 2025 outbreaks suggests some transmission chains persisted across the calendar-year boundary rather than dying out, which is the more concerning reading of the numbers.

The published counts do not indicate how many additional cases will be notified before year end, how many of the 43 outbreaks remain open, or how the 18 international-visitor cases were distributed across jurisdictions. Anyone using these figures for planning should treat the November 12 total as a floor on confirmed cases to date, not a projection.

The useful takeaway for an analyst is narrower: 2026 has already surpassed 2025 on the confirmed-case measure, and most of its growth has come through clusters rather than isolated imported cases.